Category Archives: Funding info

BioVinc Secures Multi-Million Dollar SBIR Fast-Track Grant from NIH/NIAID to Advance Treatment for Infected Fractures

BioVinc is thrilled to announce it has been awarded a prestigious multi-million dollar SBIR Fast-Track Phase I/II grant from the National Institutes of Health (NIH/NIAID). This funding will accelerate our research and development of cutting-edge treatments targeting infected fractures, a critical unmet medical need. Patients suffering from open fractures face an alarmingly high risk of…

BioVinc Awarded SBIR Phase II Grant by NIH/NIAID to Advance Novel Treatment for Prosthetic Joint Infections

BioVinc is proud to announce that it has received a multi-million prestigious SBIR Phase II grant from the National Institutes of Health (NIH/NIAID). This grant will accelerate our efforts in the research and development of new treatments targeting the significant unmet medical need of prosthetic joint infections. Deep bone infections, such as prosthetic joint infections,…